Hot key words:
Recruits IM19 drug
ClinicalTrials

Dear Sir or Madam,


Immunochina Pharmaceuticals is conducting a‘Clinical Study of CAR-T Cells for the Treatment of Relapsed and Refractory Non-Hodgkin's Lymphoma’. As a new generation of personalized precision medicine, CAR-T cellular therapy can modify the immune system through genetic engineering to specifically recognize and kill cancer cells and it has been clinically proven in the world. The study is open to recruiting subjects, and if you are eligible and willing to participate, we will provide you with free treatment and related examinations.

If you, your families or friends have relapsed and refractory non-Hodgkin's lymphoma and are 18 years of age or older, feel free to contact us and we will evaluate your condition in detail to determine if you are eligible to participate.


If you need further information, please contact Mr. Wu via:

Mobile: 15801390058

Website:http://www.startatarrium.com

Email: wufei@immunochina.com


With the greatest efforts and best service, Immunochina is committed to helping every patient to fight against leukemia. We sincerely hope that all patients will get well soon!


Dear Sir or Madam,


Immunochina Pharmaceuticals is conducting a ‘Clinical Study of CAR-T Cells for the Treatment of Relapsed and Refractory Acute B Lymphocytic Leukemia’. As a new generation of individualized precise medical technology, CAR-T cellular therapy can modify the immune system through genetic engineering to specifically recognize and kill cancer cells and it has been clinically proven in the world. The study is open to recruiting subjects, and if you are eligible and willing to participate, we will provide you with free treatment and related examinations.

If you, your families or friends have relapsed and refractory acute B lymphocytic leukemia and are not over 75 years old, feel free to contact us and we will evaluate your condition in detail to determine if you are eligible to participate.


If you need further information, please contact Mr. Wu via:

Mobile: 15801390058

Website:http://www.startatarrium.com

Email: wufei@immunochina.com


With the greatest efforts and best service, Immunochina is committed to helping every patient to fight against leukemia. We sincerely hope that all patients will get well soon!





You are welcome to call for consultation! 010-62886890
Mail:office@immunochina.com Address:3rd Floor, B1 District, Yiyuan, 80 Xingshikou Road, Haidian District, Beijing
Beijing Immunochina Pharmaceuticals Co., Ltd. Copyright 京ICP备15031757号-1 Technical support: fast help cloud
www.hg0088.com